Key facts
- It has raised $2.0M; the latest was Seed Round ($2.0M) in Jan 2026.
- Notable investors include Flare Capital Partners, SWL Healthcare Ventures, Two Sons Investments.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ethicos Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Ethicos Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ethicos Health
Developer of an AI-enabled clinical efficacy platform designed to elevate prior authorizations to make them clinically effective. The company's platform facilitates administration of clinical guidelines and manages specialty pharmacy and complex therapy costs, also offers evidence-based clinical guideline integration and healthcare technology systems, serves pharmaceutical companies and healthcare providers, enabling healthcare professionals to eliminate inappropriate medication and provide patient experience and less administrative burden on clinicians.
- Sector
- Information Technology
- HQ
- Nashville, TN, United States
- Founded
- 2023
- Employees
- 3
- Website
- ethicoshealth.com/
- Ownership
- Privately Held (backing)
Ethicos Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ethicos Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ethicos Health in its N-PORT filings yet. We sweep new filings monthly.